Mosaic ImmunoEngineering (CPMV) Receivables - Other (2011 - 2020)

Mosaic ImmunoEngineering (CPMV) posted quarterly Receivables - Other of $63.0 for Q2 2020, down 99.39% quarter-over-quarter from $10285.0 in Q1 2013.

Mosaic ImmunoEngineering (CPMV) Receivables - Other (2011 - 2020) Analysis & Trends

Mosaic ImmunoEngineering's Receivables - Other history runs 3 years deep, the most recent figure standing at $63.0 for Q2 2020.

In Q2 2020, Receivables - Other changed N/A year-over-year to $63.0; the TTM figure through May 2020 stood at $63.0 (changed N/A YoY), while the FY2020 annual figure was $63.0, changed N/A from the prior year.
Receivables - Other for Q2 2020 stood at $63.0, down from $10285.0 in the prior quarter.
The five-year high for Receivables - Other was $63.0 in Q2 2020, with the low at $63.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Mosaic ImmunoEngineering	527,536.97	527,536.97	-

Download Data